 CARLSBAD, Calif., Oct. 28, 2020 GLOBE NEWSWIRE -- GenMark Diagnostics, Inc. Nasdaq: GNMK, a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the quarter ended September 30, 2020. 